title: Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis.
abstract: Hedgehog signaling pathway activation has been implicated in the pathogenesis of NASH. Despite this concept, hedgehog pathway inhibitors have not been explored. Thus, we examined the effect of vismodegib, a hedgehog signaling pathway inhibitor, in a diet-induced model of NASH. C57BL/6 mice were placed on 3-month chow or FFC (high saturated fats, fructose, and cholesterol) diet. One week prior to sacrifice, mice were treated with vismodegib or vehicle. Mice fed the FFC diet developed significant steatosis, which was unchanged by vismodegib therapy. In contrast, vismodegib significantly attenuated FFC-induced liver injury as manifested by reduced serum ALT and hepatic TUNEL-positive cells. In line with the decreased apoptosis, vismodegib prevented FFC-induced strong upregulation of death receptor DR5 and its ligand TRAIL. In addition, FFC-fed mice, but not chow-fed animals, underwent significant liver injury and apoptosis following treatment with a DR5 agonist; however, this injury was prevented by pre-treatment with vismodegib. Consistent with a reduction in liver injury, vismodegib normalized FFC-induced markers of inflammation including mRNA for TNF-α, IL-1β, IL-6, monocyte chemotactic protein-1 and a variety of macrophage markers. Furthermore, vismodegib in FFC-fed mice abrogated indices of hepatic fibrogenesis. In conclusion, inhibition of hedgehog signaling with vismodegib appears to reduce TRAIL-mediated liver injury in a nutrient excess model of NASH, thereby attenuating hepatic inflammation and fibrosis. We speculate that hedgehog signaling inhibition may be salutary in human NASH.
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Petra
authors.initials: P
authors.lastname: Hirsova
authors.forename: Samar H
authors.initials: SH
authors.lastname: Ibrahim
authors.forename: Steven F
authors.initials: SF
authors.lastname: Bronk
authors.forename: Hideo
authors.initials: H
authors.lastname: Yagita
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Gores
mesh_terms: D000813:Anilides / Q000494:pharmacology*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D059305:Diet, High-Fat / Q000009:adverse effects; D004195:Disease Models, Animal; D015536:Down-Regulation / Q000187:drug effects; D005234:Fatty Liver / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D053823:Hedgehog Proteins / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000293:injuries* / Q000378:metabolism / Q000473:pathology; D008264:Macrophages / Q000166:cytology / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D065626:Non-alcoholic Fatty Liver Disease; D011725:Pyridines / Q000494:pharmacology*; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects*; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism*
chemical_list: D000813:Anilides; D053823:Hedgehog Proteins; C538724:HhAntag691; D011725:Pyridines; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D053221:TNF-Related Apoptosis-Inducing Ligand
references.citation: J Lipid Res. 2004 Aug;45(8):1410-7
references.pmid: 15145986
references.citation: Differentiation. 2012 Feb;83(2):S43-8
references.pmid: 22154138
references.citation: Am J Pathol. 2012 Dec;181(6):2126-37
references.pmid: 23031257
references.citation: Immunology. 2009 Jun;127(2):145-54
references.pmid: 19476510
references.citation: Gut. 2012 Sep;61(9):1323-9
references.pmid: 22427237
references.citation: PLoS One. 2011;6(9):e23943
references.pmid: 21912653
references.citation: Semin Liver Dis. 2010 Aug;30(3):245-57
references.pmid: 20665377
references.citation: Mol Cell. 2013 Mar 28;49(6):1034-48
references.pmid: 23434371
references.citation: Hepatology. 2009 Aug;50(2):518-27
references.pmid: 19575365
references.citation: Gut. 2007 Aug;56(8):1124-31
references.pmid: 17470478
references.citation: Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G825-34
references.pmid: 21836057
references.citation: Gastroenterology. 2003 Aug;125(2):437-43
references.pmid: 12891546
references.citation: Hepatology. 2013 May;57(5):1814-25
references.pmid: 23300059
references.citation: Dig Dis. 2012;30(2):158-62
references.pmid: 22722431
references.citation: Immunity. 2009 Feb 20;30(2):180-92
references.pmid: 19239902
references.citation: J Hepatol. 2011 Jan;54(1):142-52
references.pmid: 20888662
references.citation: J Biol Chem. 2011 Nov 11;286(45):39336-48
references.pmid: 21941003
references.citation: J Drug Target. 2012 Nov;20(9):770-82
references.pmid: 22994359
references.citation: Hepatology. 2012 Jun;55(6):1711-21
references.pmid: 22213086
references.citation: J Exp Med. 2004 Feb 16;199(4):437-48
references.pmid: 14769851
references.citation: Gastroenterology. 2002 Oct;123(4):1323-30
references.pmid: 12360492
references.citation: Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):201-12
references.pmid: 21476915
references.citation: Annu Rev Physiol. 2010;72:219-46
references.pmid: 20148674
references.citation: Hepatology. 2007 Jun;45(6):1366-74
references.pmid: 17476695
references.citation: Gastroenterology. 2012 May;142(5):1150-1159.e6
references.pmid: 22285806
references.citation: Physiol Rev. 2010 Jul;90(3):1165-94
references.pmid: 20664081
references.citation: Am J Gastroenterol. 2004 Sep;99(9):1708-17
references.pmid: 15330907
references.citation: J Clin Invest. 2013 Jun;123(6):2380-94
references.pmid: 23563311
references.citation: Hepatology. 2003 Nov;38(5):1188-98
references.pmid: 14578857
references.citation: Nat Med. 2012 Mar 06;18(3):363-74
references.pmid: 22395709
references.citation: Lab Invest. 2013 Jan;93(1):20-30
references.pmid: 23069937
references.citation: Sci Signal. 2012 Aug 21;5(238):pe35
references.pmid: 22912492
references.citation: Oncogene. 2010 Aug 26;29(34):4848-58
references.pmid: 20562908
references.citation: J Pathol. 2011 Jul;224(3):401-10
references.pmid: 21547909
references.citation: Clin Liver Dis. 2012 Aug;16(3):549-65
references.pmid: 22824480
references.citation: Hepatology. 2011 Jan;53(1):106-15
references.pmid: 20967826
references.citation: J Hepatol. 2009 Jul;51(1):212-23
references.pmid: 19447517